A novel fluorescence-based biosynthetic trafficking method provides pharmacologic evidence that PI4-kinase IIIα is important for protein trafficking from the endoplasmic reticulum to the plasma membrane Public Deposited

Downloadable Content

Download PDF
Creator
  • Baird, Barbara
    • Other Affiliation: Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, USA
  • Holowka, David
    • Other Affiliation: Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, USA
  • Bryant, Kirsten L.
    • Affiliation: N.C. Cancer Hospital, UNC Lineberger Comprehensive Cancer Center, School of Medicine
    • Other Affiliation: Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY, USA
Abstract
  • Abstract Background Biosynthetic trafficking of receptors and other membrane-associated proteins from the endoplasmic reticulum (ER) to the plasma membrane (PM) underlies the capacity of these proteins to participate in crucial cellular roles. Phosphoinositides have been shown to mediate distinct biological functions in cells, and phosphatidylinositol 4-phosphate (PI4P), in particular, has emerged as a key regulator of biosynthetic trafficking. Results To investigate the source of PI4P that orchestrates trafficking events, we developed a novel flow cytometry based method to monitor biosynthetic trafficking of transiently transfected proteins. We demonstrated that our method can be used to assess the trafficking of both type-1 transmembrane and GPI-linked proteins, and that it can accurately monitor the pharmacological disruption of biosynthetic trafficking with brefeldin A, a well-documented inhibitor of early biosynthetic trafficking. Furthermore, utilizing our newly developed method, we applied pharmacological inhibition of different isoforms of PI 4-kinase to reveal a role for a distinct pool of PI4P, synthesized by PI4KIIIα, in ER-to-PM trafficking. Conclusions Taken together, these findings provide evidence that a specific pool of PI4P plays a role in biosynthetic trafficking of two different classes of proteins from the ER to the Golgi complex. Furthermore, our simple, flow cytometry-based biosynthetic trafficking assay can be widely applied to the study of multiple classes of proteins and varied pharmacological and genetic perturbations.
Date of publication
Identifier
  • doi:10.1186/s12860-015-0049-5
Resource type
  • Article
Rights statement
  • In Copyright
Rights holder
  • Bryant et al.; licensee BioMed Central.
Language
  • English
Bibliographic citation
  • BMC Cell Biology. 2015 Feb 27;16(1):5
Publisher
  • BioMed Central